Thin Film Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Global Thin Film Drugs Market Size and it is segmented by Product Type (Oral Thin Film, Transdermal Thin Film), Indication (Schizophrenia, Migraine, Opioid Dependence, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market values are provided in terms of (in USD million) for the above segments.

Thin Film Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Thin Film Drugs Market Size

Thin Film Drugs Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 9.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Thin Film Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Thin Film Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Thin Film Drugs Market Analysis

The Global Thin Film Drugs Market is expected to register a CAGR of 9.3% during the forecast period.

COVID-19 had a significant impact on the growth of the market during the pandemic period. The demand for thin film products was notably affected due to the launch of innovative and advanced technologies for the treatment of COVID-19 disease. For instance, in May 2022, Thin Film Freezing Pharmaceuticals delivered a platform presentation with data on stabilizing and delivering antivirals, antibodies, and vaccines using thin film freezing technology in the fight against COVID-19 and other viral infections. Thus, the pandemic outbreak led to the introduction of advanced technologies, thereby significantly impacting the market growth during the pandemic period. In addition, the demand for thin film drugs is expected to remain intact owing to the rising focus on treating various chronic disorders, thereby contributing to the market's growth over the forecast period.

The increasing prevalence of diseases such as migraine, schizophrenia, opioid dependence, and others, along with rising demand for effective thin film drugsOpioid, are expected to contribute to the market's growth. For instance, the article published by DN article in January 2022 states that 1 in 7 people worldwide suffers from migraine annually, and 14.7% of people worldwide had migraine in 2021. The same source also mentioned that around 2% of the world's population suffers from chronic migraines annually. Similarly, according to the NCBI article published in June 2022, Opioid use disorders affect over 16 million people worldwide annually. Such increasing prevalence of migraine and Opioids prevalence is expected to drive the demand for thin film drugs, thereby contributing to the market's growth.

Furthermore, the growing investments in research and development of thin film drugs are expected to boost the market growth. For instance, in November 2022, Jurata Thin Film raised initial investment funds totaling USD 4.87 million to develop the thin film drug technology. The funds raised in this investment supported the design and built a pilot-scale manufacturing line capable of fabricating over 1,000 doses of biologic-loaded thin films per hour.

However, the availability of substitute drugs is expected to hinder pharmaceutical companies' market growth over the forecast period.

Thin Film Drugs Industry Overview

The thin film drugs market is moderately competitive and consists of several major players. Some companies currently dominating the market are ZIM Laboratories Limited, Aquestive Therapeutics, Indivior PLC, Tesa SE (Tesa Labtec GmbH), Pfizer, Inc., ARx, LLC., Solvay, IntelGenx. and others.

Thin Film Drugs Market Leaders

  1. ZIM Laboratories Limited

  2. Aquestive Therapeutics

  3. Indivior PLC

  4. Tesa Labtec GmbH

  5. Pfizer, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Thin Film Drugs.jpg
Need More Details on Market Players and Competiters?
Download PDF

Thin Film Drugs Market News

  • In November 2022, Aptar Pharma collaborated with TFF pharmaceutical; a company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform. The collaboration aimed at developing and testing the administration of dry powder vaccines utilizing thin film freezing technology.
  • In March 2022, Cure Pharmaceutical, Milagro Pharmaceuticals, and Milagro Pharmaceuticals collaborated to register and sell Cure's oral thin film drugs in Mexico.

Thin Film Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Target Disorders
    • 4.2.2 Increasing Investments for Pharmaceutical Developments
  • 4.3 Market Restraints
    • 4.3.1 Availability of Substitute Drugs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Oral Thin Film
    • 5.1.2 Transdermal Thin Film
  • 5.2 By Indication
    • 5.2.1 Schizophrenia
    • 5.2.2 Migraine
    • 5.2.3 Opioid Dependence
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ZIM Laboratories Limited
    • 6.1.2 Aquestive Therapeutics
    • 6.1.3 Indivior PLC
    • 6.1.4 Tesa SE (Tesa Labtec GmbH)
    • 6.1.5 Pfizer, Inc.
    • 6.1.6 ARx, LLC.
    • 6.1.7 Solvay
    • 6.1.8 Intelgenx Corp
    • 6.1.9 AdexPharma
    • 6.1.10 Sumitomo Dainippon Pharma Co. Ltd
    • 6.1.11 Novartis AG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Thin Film Drugs Industry Segmentation

As per the report's scope, thin film drugs have surfaced as an alternative to tablets or capsules due to their efficient therapeutic results. The drugs are made of polymers that quickly dissolve when kept in the mouth or buccal cavity, supplying the drug directly to the systemic circulation in the body. The Thin Film Drugs Market is segmented by Product Type (Oral Thin Film, Transdermal Thin Film), By Indication (Schizophrenia, Migraine, Opioid Dependence, and Others), and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The by eport also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Oral Thin Film
Transdermal Thin Film
By Indication Schizophrenia
Migraine
Opioid Dependence
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Thin Film Drugs Market Research FAQs

What is the current Global Thin Film Drugs Market size?

The Global Thin Film Drugs Market is projected to register a CAGR of 9.3% during the forecast period (2025-2030)

Who are the key players in Global Thin Film Drugs Market?

ZIM Laboratories Limited, Aquestive Therapeutics, Indivior PLC, Tesa Labtec GmbH and Pfizer, Inc. are the major companies operating in the Global Thin Film Drugs Market.

Which is the fastest growing region in Global Thin Film Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Thin Film Drugs Market?

In 2025, the North America accounts for the largest market share in Global Thin Film Drugs Market.

What years does this Global Thin Film Drugs Market cover?

The report covers the Global Thin Film Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Thin Film Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Thin Film Drug Industry Report

Statistics for the 2025 Global Thin Film Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Thin Film Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.